Acknowledgement
The work was supported by National Institutes of Health (National Heart, Lung, and Blood Institute [NHLBI] grant R01 HL117888).
References
- Lee MS, Tadwalkar RV, Fearon WF, et al. Cardiac allograft vasculopathy: a review. Catheter Cardiovasc Interv 2018;92:E527-36.
- Lund LH, Khush KK, Cherikh WS, et al. The registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus theme: allograft ischemic time. J Heart Lung Transplant 2017;36:1037-46.
- Yusen RD, Edwards LB, Dipchand AI, et al. The registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart-Lung Transplant Report-2016; Focus theme: primary diagnostic indications for transplant. J Heart Lung Transplant 2016;35:1170-84.
- Lee F, Nair V, Chih S. Cardiac allograft vasculopathy: insights on pathogenesis and therapy. Clin Transplant 2020;34:e13794.
- Lu WH, Palatnik K, Fishbein GA, et al. Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts. J Heart Lung Transplant 2011;30:1044-50.
- Abu-Qaoud MS, Stoletniy LN, Chen D, Kerstetter J, Kuhn M, Pai RG. Lack of relationship between microvascular and macrovascular disease in heart transplant recipients. Transplantation 2012;94:965-70.
- Kubrich M, Petrakopoulou P, Kofler S, et al. Impact of coronary endothelial dysfunction on adverse long-term outcome after heart transplantation. Transplantation 2008;85:1580-7.
- Awad M, Czer LS, Hou M, et al. Early denervation and later reinnervation of the heart following cardiac transplantation: a review. J Am Heart Assoc 2016;5:e004070.
- Gao SZ, Alderman EL, Schroeder JS, Hunt SA, Wiederhold V, Stinson EB. Progressive coronary luminal narrowing after cardiac transplantation. Circulation 1990;82:IV269-75.
- Sharples LD, Jackson CH, Parameshwar J, Wallwork J, Large SR. Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy. Transplantation 2003;76:679-82.
- St Goar FG, Pinto FJ, Alderman EL, et al. Detection of coronary atherosclerosis in young adult hearts using intravascular ultrasound. Circulation 1992;86:756-63.
- Pollack A, Nazif T, Mancini D, Weisz G. Detection and imaging of cardiac allograft vasculopathy. JACC Cardiovasc Imaging 2013;6:613-23.
- Ricci MA, Trevisani GT, Pilcher DB. Vascular complications of cardiac catheterization. Am J Surg 1994;167:375-8.
- Tadic M. Multimodality evaluation of the right ventricle: an updated review. Clin Cardiol 2015;38:770-6.
- Ferreira VM, Piechnik SK, Robson MD, Neubauer S, Karamitsos TD. Myocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mapping. J Thorac Imaging 2014;29:147-54.
- Puntmann VO, Valbuena S, Hinojar R, et al. Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I - analytical validation and clinical qualification. J Cardiovasc Magn Reson 2018;20:67.
- Moon JC, Messroghli DR, Kellman P, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 2013;15:92.
- Giri S, Chung YC, Merchant A, et al. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 2009;11:56.
- Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004;52:141-6.
- Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S. Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson 2017;18:89.
- Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.
- Dolan RS, Rahsepar AA, Blaisdell J, et al. Cardiac structure-function MRI in patients after heart transplantation. J Magn Reson Imaging 2019;49:678-87.
- Dolan RS, Rahsepar AA, Blaisdell J, et al. Multiparametric cardiac magnetic resonance imaging can detect acute cardiac allograft rejection after heart transplantation. JACC Cardiovasc Imaging 2019;12:1632-41.
- Mehra MR, Crespo-Leiro MG, Dipchand A, et al. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant 2010;29:717-27.
- Markl M, Rustogi R, Galizia M, et al. Myocardial T2-mapping and velocity mapping: changes in regional left ventricular structure and function after heart transplantation. Magn Reson Med 2013;70:517-26.
- Yuan Y, Cai J, Cui Y, et al. CMR-derived extracellular volume fraction (ECV) in asymptomatic heart transplant recipients: correlations with clinical features and myocardial edema. Int J Cardiovasc Imaging 2018;34:1959-67.
- Miller CA, Sarma J, Naish JH, et al. Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy. J Am Coll Cardiol 2014;63:799-808.
- Chih S, Ross HJ, Alba AC, Fan CS, Manlhiot C, Crean AM. Perfusion cardiac magnetic resonance imaging as a rule-out test for cardiac allograft vasculopathy. Am J Transplant 2016;16:3007-15.
- Erbel C, Mukhammadaminova N, Gleissner CA, et al. Myocardial perfusion reserve and strain-encoded CMR for evaluation of cardiac allograft microvasculopathy. JACC Cardiovasc Imaging 2016;9:255-66.
- Korosoglou G, Osman NF, Dengler TJ, et al. Strain-encoded cardiac magnetic resonance for the evaluation of chronic allograft vasculopathy in transplant recipients. Am J Transplant 2009;9:2587-96.
- Korosoglou G, Riedle N, Erbacher M, et al. Quantitative myocardial blush grade for the detection of cardiac allograft vasculopathy. Am Heart J 2010;159:643-651.e2.
- Braggion-Santos MF, Lossnitzer D, Buss S, et al. Late gadolinium enhancement assessed by cardiac magnetic resonance imaging in heart transplant recipients with different stages of cardiac allograft vasculopathy. Eur Heart J Cardiovasc Imaging 2014;15:1125-32.
- van Heeswijk RB, Bastiaansen JA, Iglesias JF, et al. Quantification of myocardial interstitial fibrosis and extracellular volume for the detection of cardiac allograft vasculopathy. Int J Cardiovasc Imaging 2020;36:533-42.
- Ajluni SC Jr, Mously H, Chami T, et al. Non-invasive imaging in the evaluation of cardiac allograft vasculopathy in heart transplantation: a systematic review. Curr Probl Cardiol 2022;101103.
- Sciaccaluga C, Ghionzoli N, Mandoli GE, et al. The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences. Heart Fail Rev 2021 Aug 12 [E-pub ahead of print], https://doi.org/10.1007/s10741-021-10155-0.
- Costanzo MR, Dipchand A, Starling R, et al. The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010;29:914-56.
- Elkaryoni A, Abu-Sheasha G, Altibi AM, Hassan A, Ellakany K, Nanda NC. Diagnostic accuracy of dobutamine stress echocardiography in the detection of cardiac allograft vasculopathy in heart transplant recipients: a systematic review and meta-analysis study. Echocardiography 2019;36:528-36.
- Clerkin KJ, Ali ZA, Mancini DM. New developments for the detection and treatment of cardiac vasculopathy. Curr Opin Cardiol 2017;32:316-25.
- Clerkin KJ, Farr MA, Restaino SW, Ali ZA, Mancini DM. Dobutamine stress echocardiography is inadequate to detect early cardiac allograft vasculopathy. J Heart Lung Transplant 2016;35:1040-1.
- Akosah KO, Mohanty PK, Funai JT, et al. Noninvasive detection of transplant coronary artery disease by dobutamine stress echocardiography. J Heart Lung Transplant 1994;13:1024-38.
- Masarone D, Kittleson M, Gravino R, Valente F, Petraio A, Pacileo G. The role of echocardiography in the management of heart transplant recipients. Diagnostics (Basel) 2021;11:2338.
- Clemmensen TS, Eiskjaer H, Logstrup BB, Ilkjaer LB, Poulsen SH. Left ventricular global longitudinal strain predicts major adverse cardiac events and all-cause mortality in heart transplant patients. J Heart Lung Transplant 2017;36:567-76.
- Pober JS, Chih S, Kobashigawa J, Madsen JC, Tellides G. Cardiac allograft vasculopathy: current review and future research directions. Cardiovasc Res 2021;117:2624-38.
- Schepis T, Achenbach S, Weyand M, et al. Comparison of dual source computed tomography versus intravascular ultrasound for evaluation of coronary arteries at least one year after cardiac transplantation. Am J Cardiol 2009;104:1351-6.
- Shah NR, Blankstein R, Villines T, Imran H, Morrison AR, Cheezum MK. Coronary CTA for surveillance of cardiac allograft vasculopathy. Curr Cardiovasc Imaging Rep 2019;12:1-7.
- Oebel S, Hamada S, Higashigaito K, et al. Comprehensive morphologic and functional imaging of heart transplant patients: first experience with dynamic perfusion CT. Eur Radiol 2018;28:4111-21.
- Gunther A, Andersen R, Gude E, et al. The predictive value of coronary artery calcium detected by computed tomography in a prospective study on cardiac allograft vasculopathy in heart transplant patients. Transpl Int 2018;31:82-91.
- Zerhouni EA, Parish DM, Rogers WJ, Yang A, Shapiro EP. Human heart: tagging with MR imaging--a method for noninvasive assessment of myocardial motion. Radiology 1988;169:59-63.
- Aletras AH, Ding S, Balaban RS, Wen H. DENSE: displacement encoding with stimulated echoes in cardiac functional MRI. J Magn Reson 1999;137:247-52.